Portfolio news 0

Tissue Regenix Group (AIM:TRX) the regenerative medical devices company announces that it has written to all registered shareholders regarding its intention to adopt electronic communication methods for shareholder documents.

Tissue Regenix is seeking to adopt electronic communication in order to improve the Company's environmental sustainability efforts and ensure timely and cost-effective communications with all shareholders.

A letter has been posted to all registered shareholders from the Company's registrar, Link Group, and a copy of this letter will also be made available on the Company's website.

Shareholders wishing to continue to receive shareholder documents in printed form will need to notify Link Group no later than 10 March 2021 by completing and returning the response form within the letter, or through registering for a shareholder account on: www.signalshares.com

Those shareholders who do not return the response form will be deemed to have consented to receiving shareholder documents or information (including the annual report and notices of Company meetings) by means of the Tissue Regenix Group website: www.tissueregenix.com 

A notice via email or mail, subject to the shareholder preference identified, will be sent to shareholders when new materials are available online including the annual report. Shareholders are entitled to change their preference of communication at any time in the future.

 

For more Information:

 

Tissue Regenix Group plc	www.tissueregenix.com Via Walbrook PR
David Cocke,  Chief Financial Officer
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)	Tel: +44 (0)207 710 7600
Ben Maddison / Alex Price
Walbrook PR Ltd	Tel: +44 (0)20 7933 8780 [email protected]
Paul McManus / Alice Woodings / Lianne Cawthorne